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Abstract
Mitochondrial apoptosis pathway is an important target of cardioprotective signalling. Tanshinones, a group of major
bioactive compounds isolated from Salvia miltiorrhiza, have been reported with actions against inflammation, oxidative
stress, and myocardial ischemia reperfusion injury. However, the actions of these compounds on the chronic hypoxia-
related mitochondrial apoptosis pathway have not been investigated. In this study, we examined the effects and molecular
mechanisms of two major tanshonones, tanshinone IIA (TIIA) and cryptotanshinone (CT) on hypoxia induced apoptosis in
H9c2 cells. Cultured H9c2 cells were treated with TIIA and CT (0.3 and 3 mM) 2 hr before and during an 8 hr hypoxic period.
Chronic hypoxia caused a significant increase in hypoxia inducible factor 1a expression and the cell late apoptosis rate,
which was accompanied with an increase in caspase 3 activity, cytochrome c release, mitochondria membrane potential and
expression of pro-apoptosis proteins (Bax and Bak). TIIA and CT (0.3 and 3 mM), in concentrations without affecting the cell
viability, significantly inhibited the late apoptosis and the changes of caspase 3 activity, cytochrome c release, and
mitochondria membrane potential induced by chronic hypoxia. These compounds also suppressed the overexpression of
Bax and reduced the ratio of Bax/Bcl-2. The results indicate that TIIA and CT protect against chronic hypoxia induced cell
apoptosis by regulating the mitochondrial apoptosis signaling pathway, involving inhibitions of mitochondria
hyperpolarization, cytochrome c release and caspase 3 activity, and balancing anti- and pro-apoptotic proteins in Bcl-2
family proteins.
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Introduction
Myocardial hypoxia is closely associated with cardiac dysfunc-
tions, in particular myocardial infarction (MI), ischemia reperfu-
sion injury, and hypertrophy [1]. Hypoxia can cause changes of
important cell signalling mechanisms involved in regulation of
mitochondrial function, intracellular calcium and pH homeostasis,
resulting in oxidative stress which subsequently induce cell death
via apoptosis or/and necrosis [2].
The mitochondria dependent intrinsic apoptosis pathway plays
an important role in cardiac cell injury under various pathological
conditions [3]. For example, there is strong evidence that
mitochondria transition pore opening (MPTP) is involved in stress
induced cardiac cell damage and cell death [4]. The event of
MPTP opening is affected by various factors including intracel-
lular Ca2+, oxidative radicals, ATP levels and Bcl-2 family proteins
[5]. MPTP opening causes a transient hyperpolarization, followed
by depolarization, of the mitochondria membrane, which in turn
causes the release of apoptotic proteins such as cytochrome c, smac
and apoptosis inducing factor (AIF), resulting in caspase 3
activation and apoptosis. Other drivers of MPTP opening include
Bcl-2 family proteins, in particular pro-apoptotic (Bax, Bak and
Bad) proteins but also involving anti-apoptotic (Bcl-2, Bcl-xl)
proteins [6,7]. Cardiac cells under prolonged hypoxia condition
have been shown with mitochondrial damage and apoptosis,
including changes in cytochrome c release, caspase 3 activation
and Bcl-2 family proteins [8]. It has been known that Bcl-2 family
proteins are regulated by hypoxia inducible factor 1a (HIF-1a), a
protein highly activated in low oxygen condition [9]. A previous
study has reported that increased expression of HIF-1a and its
regulated genes by hypoxia was associated with cell apoptosis and
Bax and Bcl-xl proteins via stimulation of Bnip3 and p-53 proteins
[10].
Tanshinones are a group of bioactive compounds isolated from
Salvia miltiorrhiza (Danshen), a traditionally medicinal plant used for
treating angina pectoris, atherosclerosis and MI [11]. Tanshinone
IIA (TIIA) and cryptotanshinone (CT) are two major bioactive
tanshinone [12]. They have reported with actions against
inflammation, oxidative stress, myocardial infarction, and myo-
cardial ischemia reperfusion injury [13]. For example, studies in
neonatal cardiomyocytes have revealed a vasodilation action and
anti-apoptosis effects of TIIA [14,15] by attenuating ROS level
and enhancing Bcl-2 protein expression. TIIA has also been
shown with anti-inflammatory effects, by reducing monocyte
chemoattractant protein-1 (MCP-1) expression in cardiac fibro-
blasts [16]. In vivo studies have demonstrated that TIIA reduced
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MI size, an effect was associated with inhibition of expression of
tumor necrosis factor-a (TNF-a), MCP-1, and nuclear transcrip-
tion factor-kappa B (NF-kappa B) [16]. Similarly, CT has been
shown with anti-inflammatory actions by inhibition of expressions
of NF-kB and matrix metalloproteinases-9 (MMP-9) and vasodi-
lator actions by reduction of calcium influx or attenuating
expressions of I/R injuries via suppressing TNF-a and inter-
leukin1b in cultured cells or in vivo [17,18,19]. However, the
actions of TIIA and CT on chronic hypoxia induced cardiac cell
injury have still not been investigated, especially on the
mechanisms involving MPTP and mitochondrial apoptosis path-
way. Thus, in this study, we examined the effects and mechanisms
of TIIA and CT on hypoxia induced apoptosis in H9c2 cells.
Results
Effects of TIIA and CT on Cell Viability in H9c2 Cells
TIIA and CT (0.01–10 mM) did not significantly affect cell
viability in H9c2 cells (P.0.05) (Figure 1).
Effects of TIIA and CT on Hypoxia Induced HIF-1a
Stabilization
Prolonged hypoxia can cause a distinctive change in cellular
signalling by stabilization of HIF-1a. Activated HIF-1a can
regulate mitochondrial proteins and interact with other signalling
molecules, such as NO, to cause cell damages [2,9]. Thus, western
blot was carried out first to determine whether HIF-1a was
involved in our experimental hypoxia condition, and then to
determine the effects of TIIA and CT on the stabilization of HIF-
1a. To specify HIF-1a translocation and stabilization, cell nuclear
fractions were isolated and subjected to western blot. In the
hypoxia control group, a significant increase in HIF-1a stabiliza-
tion was detected with a 1.7 fold increase than that of the
normoxia group. Cells treated with TIIA and CT showed a
tendency of decreased expression of HIF-1a, compared to the
hypoxia control, although they did not reach a statistical
significance level, except TIIA 3 mM showed a significant
degradation on hypoxia induced HIF-1a accumulation (from 1.7
to 1.1 fold, Figure 2). Effects of TIIA and CT on Hypoxia Induced Apoptosis
To examine the chronic hypoxia induced cellular morpholog-
ical changes and the types of cell apoptosis, we assessed the cell
apoptosis/necrosis by a fluorescence assay. Three fluorescence
probes (Hoechst 33342, YO-PRO-1 and propidium iodide) were
used to distinguish the cell damages by the extent of nuclear
chromatin condensation and plasma membrane permeability.
Analysed images of viable (green), early apoptotic (blue), late
apoptotic (pink), and necrotic cells (red) are shown in Figure 3A. In
normoxia cells, a high cell viable rate (92.563.1%) was observed,
with 4.964.1% of early apoptosis, 2.761.6% of late apoptosis,
and no necrosis. In contrast, hypoxia cells showed a significant
increase in late apoptosis (17.963.5%), although the changes of
early apoptosis and necrosis rate were not significant (Figure 2B).
Hypoxia cells pre-treated with TIIA and CT (0.3 and 3 mM)
showed a significant increase in the cell survival rate and
attenuated late apoptosis rate, an effect similar to cyclosporin A
(CsA, 0.1 mM), an inhibitor of MPTP opening (Figure 3B). In
addition, the caspase 3 activity, a key stimulator of cell apoptosis in
intrinsic pathway, was significantly activated (by 1.6 fold) under
the hypoxia condition. The hypoxia-induced caspase 3 activation
was significantly inhibited by both TIIA and CT (0.3 and 3 mM),
as well as specific caspase 3 inhibitor, Ac-DEVD-CHO (20 mM)
(Figure 4).
Figure 1. Effects of TIIA and CT on cell viability in H9c2 cells.
TIIA and CT (0.01 mM -10 mM) were added and incubated for 24 hr. Cell
viability was determined by MTT assay. Values are mean 6 SEM from
n= 3, ns: not significant compared to normal (P.0.05).
doi:10.1371/journal.pone.0051720.g001
Figure 2. Effects of TIIA and CT on hypoxia induced HIF-1a
stabilization in H9c2 cells. Equal amounts (25 mg) of the lysates
were used for western blotting for HIF-1a antibody on 8% SDS-PAGE
gel. Values shown are mean6 SEM from n=4, * P,0.05 vs. normoxia,#
P,0.05 vs. hypoxia.
doi:10.1371/journal.pone.0051720.g002
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Effects of TIIA and CT on Hypoxia Induced of
Mitochondrial Membrane Potential
To determine the association of cell apoptosis with MPTP, we
measured the change of mitochondrial membrane potential as an
indicator of MPTP opening. H9c2 cells were loaded with a
mitochondria selective, cell-permeant and cationic fluorescent
probe, TMRM. As shown figure 5A and B, cells exposed to 8 hr
hypoxia exhibited a significant increase in membrane potential
(2.1 fold increase) compared to normoxia group, indicating a
hyperpolarization of mitochondria membrane. Hypoxia induced
hyperpolarization was significantly less when the cells pre-treated
with TIIA and CT (0.3 and 3 mM) (Figure 5B). For example, 3 mM
TIIA group (129.668.9%) preserved membrane potential similar
to the normoxia group. The mitochondria hyperpolarization was
also inhibited by CsA (0.1 mM), an inhibitor of MPTP.
Effects of TIIA and CT on Hypoxia Induced Cytochrome C
Translocation
Cytochrome c release from mitochondria by opening of MPTP
is a critical event promoting intrinsic death pathway by apoptotic
protease activating factor 1 (Apaf-1) mediated caspase 3 activation
and apoptosis [20]. We next examined the effects of TIIA and CT
on cytochrome c translocation during the hypoxia. The cyto-
chrome c translocation was determined by immunofluorescence
assay as described in method. In the normoxia cells, cytochrome c
displayed punctuates cytoplasmic staining, which is in agreement
with its localization in mitochondria. Cells underwent hypoxia
illustrated a diffused cytoplasmic staining as results of mitochon-
drial integrity loss (Figure 6A). In the hypoxia cells, there was a
significant increase in cytochrome c translocation (1.72 fold of the
normoxia control), which was significantly inhibited by TIIA (0.3
and 3 mM) and CsA (0.1 mM) (Figure 6B). CT also showed a
tendency to inhibit the cytochrome c translocation, although it did
not reach the statistically significant level.
Effects of TIIA and CT on Bcl-2 Proteins Expression
The balance of anti- and pro-apoptotic proteins in Bcl-2 family
plays an important role in the control MPTP opening and cell
survival against ischemia reperfusion injuries [20]. To determine
whether hypoxia induced cell apoptosis is associated with Bcl-2
family proteins, the expression of anti-apoptotic (Bcl-2 and Bcl-xl)
and pro-apoptotic (Bax and Bak) proteins were determined by
western blot. There was a tendency of decrease in expressions of
Bcl-2 and Bcl-xl protein expressions under the hypoxia condition,
although the changes were not reached the statistically significant
level (Figure 7A). In contrast, expressions of Bax and Bak were
significantly increased after 8 hr hypoxia (Figure 7B). Cells treated
with TIIA (3 mM) and CT (0.3 and 3 mM) showed a significant
increase in the expressions of Bcl-2 and Bcl-xl, but a decrease in
expressions of Bax and Bak (Figure 7A and B), compared to the
hypoxia control, thus the increase in Bax/Bcl-2 ratio induced by
hypoxia was inhibited by both TIIA and CT (Figure 7C).
Discussion
The main finding of the present study is that TIIA and CT
protected against apoptosis in H9c2 cells induced by chronic
hypoxia via acting on the mitochondrial apoptosis signalling
pathway. To our knowledge, this is the first evidence on the
molecular mechanism of tanshinones on protecting chronic
hypoxia induced apoptosis in H9c2 cells.
Myocardial hypoxia is a main cause of cardiac dysfunction due
to its triggering cell injury, apoptosis and/or necrosis [1,21].
Under the present experimental condition, exposure of H9c2 cells
to an 8 hr hypoxia caused a significant cell injury and changes in
cell signalling, including cell apoptosis rate, HIF-1a activation,
disturbance of mitochondria membrane potential, and caspase 3
activation, cytochrome c translocation, and imbalance of anti- and
pro-apoptotic proteins in Bcl-2 family proteins, indicating an
activation of mitochondria apoptosis pathway. The present
observation is consistent with previous studies on apoptosis
signalling pathways in H9c2 cells under hypoxia conditions
[22,23]. It is likely that the main cause of cell injury or death
under the chronic hypoxia condition was due to late apoptosis, as
characterised by condensed chromatin and nuclear, and changes
in permeability of cell membrane which can cause mitochondrial
membrane disturbance. This is supported by other findings on
cytochrome c translocation and caspase 3 activation in doxoru-
bicin induced cell apoptosis [24] and I/R injuries in rats [25].
The observed cell apoptosis and changes in signalling molecules
are most likely to be associated with mitochondrial dysfunction, as
demonstrated with a change in mitochondria membrane potential
as an indication of MPTP opening, as reported previously [26].
Figure 3. Effects of TIIA, CT and cyclosporin A (CsA) on hypoxia induced apoptosis. (A) Representative cell images from H9c2 cells staining
with Hoechst 33342 (blue), YO-PRO-1 (green) and PI (red) as described in method. Analysed images show viable (green), early apoptosis (blue), late
apoptosis (pink) and necrosis (red) cells respectively. (B) Mean data show subpopulations of viable cells (Hoechst 33342+), early apoptotic cells
(Hoechst 33342+ and YO-PRO-1+), late apoptotic cells (Hoechst 33342+, YO-PRO-1+, PI+) and necrotic cells (Hoechst 33342+ and PI+) respectively.
Values shown are mean 6 SEM from n=5. * P,0.05 vs. normoxia, # P,0.05 vs. hypoxia, ## P,0.01 vs. hypoxia, *** P,0.001 vs. normoxia, ###
P,0.001 vs. hypoxia.
doi:10.1371/journal.pone.0051720.g003
Figure 4. Effects of TIIA, CT and a caspase 3 inhibitor Ac-DEVD-
CHO (20 mM) on hypoxia induced caspase 3 activation. The
values of caspase 3 activity were normalized by normoxia group. Values
shown are mean 6 SEM from n=4, * P,0.05 vs. normoxia, # P,0.05 vs.
hypoxia, ** P,0.01 vs. normoxia, ### P,0.001 vs. hypoxia.
doi:10.1371/journal.pone.0051720.g004
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The disturbance in mitochondria membrane potential may be
resulted from altered mitochondria transport of proton in electron
transport chain and manifested as de- and hyper-polarization [27].
The finding that TIIA and CT treatments prevented or reduced
the hypoxia induced mitochondria membrane hyperpolarization
may be related to their effects on mitochondria apoptosis signalling
pathway (e.g. via cytochrome c release and caspase 3 activation
and Bax/Bcl-2 proteins). The findings provide an explanation of
cardioprotective actions of tanshinones against cell injuries
involving mitochondria pathway. Previous studies have reported
anti-apoptotic actions of TIIA against I/R injuries and angiotensin
II induced apoptosis in PC12 cells [28] and neonatal cardiomy-
ocytes [29] respectively, by suppressing caspase 3 activity and
increasing Bcl-2 expression. TIIA has also been shown to regulate
mitochondrial membrane potential in b-amyloid induced cortical
neurons apoptosis [30]. Similarly, the anti-apoptotic effects of CT
has been shown previously with conserving mitochondrial
membrane potential, reducing Bax/Bcl-2 ratio and inhibiting
cytochrome c release in nitric oxide induced neuroblastoma cells
apoptosis [31]. It is possible that the anti-apoptotic actions of TIIA
and CT observed in the present study are associated with not only
direct action of these compounds on the intrinsic pathway and but
also the antioxidant actions of tanshinones [15,24], as there are
evidence that the hyperpolarization of mitochondria membrane
regulates mitochondrial ROS generation [32,33]. Further studies
are necessary to elucidate the role of ROS in the protection by
tanshinones of chronic hypoxia-induced cell injury in H9c2 cells.
It has been well established that Bcl-2 family proteins play an
important role in maintaining mitochondrial function and
mediating cardiac protections of various therapeutic agents [34].
Overexpression of Bcl-2 has been linked to protection of cell
apoptosis by inhibition of cytochrome c releases [35], while
Figure 5. Effects of TIIA, CT, and CsA on hypoxia induced hyperpolarization in mitochondrial membrane. (A) Images of cells stained
with TMRM in normoxia control cells and cells after 8 hr hypoxia. (B) Quantitative data of TMRM fluorescence intensity measured by microplate
reader. Values shown are mean 6 SEM from n= 3, *** P,0.001 vs. normoxia, ### P,0.001 vs. hypoxia.
doi:10.1371/journal.pone.0051720.g005
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depletion of Bax protein has been shown to reduce cell death in
ischemia reperfusion injury in mice [36]. TIIA has been
demonstrated to decrease Bax/Bcl-2 ratio in a rat model of
ischemia reperfusion injuries in vivo [25], and to regulate Bax/Bcl-
2 ratio in neonatal cardiomyocytes treated with doxorubicin [15].
In the present study, we demonstrated that both TIIA (3 mM) and
CT (0.3 and 3 mM) significantly inhibited Bax and Bak expres-
sions, but increased Bcl-2 and Bcl-xl expressions under the chronic
hypoxia condition, resulting in a reduced Bax/Bcl-2 ratio and
increased cell survival rate. Interestingly, under the hypoxia
condition, the Bak expression was markedly elevated, while that of
Bcl-xl was not significantly changed. Previous studies showed that
Bak protein could be sequestered not only by Bcl-xl but also by
Mcl-l (a member of anti-apoptotic proteins of Bcl-2 family
proteins) [37]. Thus, it is possible that the Bak protein activation
in the present study may involve inactivation of Mcl-1 protein by
chronic hypoxia. It is not clear if the change of Bak expressions by
TIIA and CT in this study was resulted from their actions on Bcl-
xl protein or involved Mcl-1 protein. Further study is necessary to
confirm the further mechanism involved.
Previous studies have reported that increased HIF-1a and HIF-
regulated gene expressions by hypoxia are associated with cell
apoptosis, possibly by stimulation of Bnip3 protein and p53
protein which subsequently influences in Bax and Bcl-xl proteins
in mitochondria [38]. The elevated Bax and HIF-1a expressions
as observed in the present study indicate a possible link between
these signalling molecules. This is also supported by our
observation in a separate microarray study that showed significant
increase in Bnip3 gene expression in H9c2 cells under the same
hypoxia condition (Data not shown), indicating a possibility of
involving HIF-1a activation via p53 upregualtion on Bax
upregulation induced by hypoxia. Interestingly, TIIA has been
shown to decrease HIF-1a protein translocation induced by
lipopolysaccharide (LPS) in mice lung [39] and down regulating
p53 protein expression in PC12 cells [40]. Thus it is possible that
TIIA may act via HIF-1a dependent p53 signalling pathway in
H9c2 cells.
In conclusion, we have demonstrated that TIIA and CT can
prevent chronic hypoxia induced H9c2 cells apoptosis by targeting
mitochondrial death pathway via balancing in anti- and pro-
apoptotic proteins in Bcl-2 family proteins and inhibition of
mitochondria membrane hyperpolarization, cytochrome c trans-
location, caspase 3 activity and inactivation of HIF-1a protein.
These mechanisms may be involved in mediating cardiac
protective actions of tanshinones in hypoxia and ischemic
conditions.
Materials and Methods
Chemicals
Tansinone IIA (TIIA) and cryptotanshinone (CT) were
purchased from National Institute for the Control of Pharmaceu-
Figure 6. Effects of TIIA, CT and CsA on hypoxia induced
cytochrome c translocation. (A) Cell images illustrate mitochondria
labelling with MitoTracker Orange CMTMRos (MitoTracker) (red) and
cytochrome c (green) in H9c2 cells under normoxia and hypoxia
conditions, and the effects of TIIA, CT and CsA treatments (yellow arrow:
cytochrome c release). (B) Quantitative data of cytochrome c diffusion
rate. H9c2 cells were scored as having cytochrome c in mitochondria
defined by punctuate (no cytochrome c release) or cytochrome c
release to cytosolic distinguished by diffused staining and overtaking
mitochondrial staining. Mean data from 500 cells per group in 3
independent experiments. * P,0.05 vs. normoxia, # P,0.05 vs. hypoxia,
## P,0.01 vs. hypoxia.
doi:10.1371/journal.pone.0051720.g006
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tical and Biological Products (.99% purity) (Beijing, China).
Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine
serum (FBS), penicillin and streptomycin were purchased from
Gibco BRL (NY, USA). GasPakTM EZ Anaerobe Container
System Sachets with Indicator and GasPakTM EZ Standard
Incubation Container were from Becton Dickinson and company
(Sydney, Australia). Trypsin-EDTA solution, Bradford reagent,
Bicinchoninic Acid Kit, protease inhibitor cocktail, Hoechst33342,
propidium iodide (PI), cyclosporin A (CsA), dimethyl sulfoxide,
tetramethylrhodamine methyl esters (TMRM), 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and caspase
3 assay kit (colorimetric) were from Sigma-Aldrich (MO, USA).
HIF-1a, Bcl-2, Bcl-xl, cytochrome c and b-actin antibodies, goat
anti-mouse IgG-HRP and goat anti-rabbit IgG-HRP were product
of Santa Cruz Biotechnology. Bax and Bak were purchased from
Cell signaling Technology (MA, USA). Alexa Fluor H488
conjugated goat anti-mouse IgG, YO-PRO-1, DAPI and Mito-
Tracker Orange CMTMRos was purchased from Molecular
Probes (San Francisco, USA). SuperSignal West Pico Chemilu-
minescent substrate and NE-PER Nuclear and Cytoplasmic
Protein Extraction Reagents were purchased from Thermo
Scientific (Rockford, USA).
Cell Culture and Hypoxia
The H9c2 embryonic rat heart-derived cells were obtained from
American Type Culture Collection (ATCC; VA, USA) and
maintained in Dulbecco’s modified Eagle’s medium supplemented
with 10% v/v fetal bovine serum and 100 mg/ml penicillin/
streptomycin at 37uC in a humidified atmosphere containing 5%
CO2 (passage 25–35).
To induce hypoxia, cells were placed in a GasPak EZ Gas
generating Pouch System for 8 hr and incubated with serum free
and glucose free DMEM as described previously [41]. As
normoxia control, serum free DMEM was added to cells and
incubated for 8 hr in normoxia condition (21% O2).
Drug Treatment
Cells were treated with TIIA or CT (0.3 and 3 mM),
respectively, 2 hr before inducing the hypoxia and during the
hypoxia period. The experimental condition was established from
a preliminary study involving different concentration of tanshi-
nones (0.1–10 mM) at different (2 and 24 hr) pre- and post-hypoxia
incubation periods. In some experiments, CsA (0.1 mM) was added
1 hr before induction of hypoxia as a positive control. Ac-DEVD-
CHO (20 mM), caspase 3 inhibitor, was treated 30 mins before
adding the caspase 3 substrate.
MTT Assay
To determine effects of TIIA and CT on cell viability in H9c2
cells, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) assay was performed as described previously [42].
Briefly, cells (56104 cells/ml) were seed in 96-wells. After 2 days of
culture, TIIA and CT (0.01 and 10 mM) were added and
incubated for 24 hr. At the end of the incubation, MTT solution
was added to each well at a final concentration of 0.5 mg/ml and
incubated for 4 hr at 37uC. Then, the culture medium was
discarded and 150 ml DMSO was added to each well to dissolve
dark blue formazan crystals. The absorbance was read at 570 nm
using FLUOstar Omega plate reader (BMG LABTECH, Orten-
berg, Germany).
Apoptosis and Necrosis Assay
Cell apoptosis and necrosis were assessed by using a combined
fluorescent staining with Hoechst 33342, YO-PRO-1and propi-
dium iodide (PI) as previously described [43]. Briefly, at the end of
hypoxia period, Hoechst 33342 (0.5 mg/ml), YO-PRO-1 (0.1 mM),
and PI (0.1 mg/ml) were added to each well and incubated for
30 mins at 37uC. The cell images were automatically obtained
using Image Xpress MICRO system (Molecular Devices, CA,
USA) at 20X magnification with binning of 1 and gain of 2 using
laser-based focusing. Images were captured using a DAPI filter
(350/70 nm Ex, 470/50 nm Em for Hoechst 33342), GFP filter
(490/40 nm Ex, 510/50 nm Em for YO-PRO-1) and Cy3 filter
(550/35 nm Ex, 570/30 nm Em for PI). The cell images were
analysed by using Cell Health program in Meta express software
(Molecular Devices).
Caspase-3 Activity Assay
Caspase-3 activity was determined by colorimetric assay kit
(Sigma Aldrich, MO, USA) according to manufacturer’s instruc-
tion. Briefly, after the hypoxia period, cells were incubated with
the lysis buffer (16107/100 ml) for 30 mins and the lysate were
centrifuged at 10,000 g for 5 mins. Protein concentrations in
supernatant were determined by Bradford protein assay. Fifty ml of
cell lysate containing 100 mg/50 ml protein were incubated with
50 ml assay buffer including 200 mM caspase 3 substrate (N-acetyl-
Asp-Glu-Val-Asp-p-nitroaniline(Ac-DEVD-pNA)) for 4 hr at
37uC. The amount of free pNA (yellow colour) was determined
by FLUOstar Omega microplate reader (BMG LABTECH) at
405 nm, which is proportional to the amount of DEVDase
(caspase-3) activity present in the sample.
Western Blot Analysis
For whole cell lysate preparations, cultured H9c2 cells were
harvested by scraping and centrifugation, washed with PBS, and
re-suspended in 100 ml/106 cells RIPA buffer (150 mM NaCl, 1%
Nonider P-40, 0.5% deoxycholate, 0.1% sodium dodecylsulfate,
50 mM Tris-hydrochloric acid, 2 mM phenylmethylsulfonylfluor-
ide, and protease inhibitor cocktail, pH 7.4). The cell lysate was
homogenised by pipetting and incubated on ice for 20 mins. After
the incubation, cell lysate was centrifuged at 13,000 g for 10 mins.
Supernatant was collected and stored at 280uC till use. The
protein content was measured by bicinchoninic acid protein assay.
To specify HIF-1a translocation and stabilization, nuclear
fractions were subjected to western blot. Nuclear fractions were
isolated according to manufacture’s instruction using NE-PER
Nuclear and Cytoplasmic Protein Extraction Reagents (Thermo
Scientific, Rockford, USA). The protein content was measured by
Bradford protein assay.
Whole cell lysates (20–80 mg) were subjected to 12% SDS-
PAGE (Bcl-2, Bcl-xl, Bax and Bak) and transferred onto a
nitrocellulose membrane. Nuclear fractions (25 mg) were subjected
to 8% SDS-PAGE (HIF-1a) and transferred onto a nitrocellulose
membrane.
After blocking with 5% nonfat milk for 1 hr at room
temperature, blots were probed with HIF-1a (1:500), Bcl-2 and
Figure 7. Effects of TIIA and CT on expressions of Bcl-2 family proteins on hypoxia induced H9c2 cells. (A) Anti-apoptotic proteins
expression: Bcl-2 protein (50 mg) and Bcl-xl protein (20 mg) expression. (B) Pro-apoptotic proteins expression: Bak and Bax proteins expression (80 mg).
(C) Bax/Bcl-2 ratio. Data shown are representative mean 6 SEM of 4–5 independent experiments. * P,0.05 vs. normoxia, # P,0.05 vs. hypoxia, ##
P,0.01 vs. hypoxia, *** P,0.001 vs. normoxia, ### P,0.001 vs. hypoxia.
doi:10.1371/journal.pone.0051720.g007
Tanshinones Protect against Cell Apoptosis
PLOS ONE | www.plosone.org 8 January 2013 | Volume 8 | Issue 1 | e51720
Bcl-xl antibody (1:500), Bax and Bak antibody (1:1,000) at 4uC
over night. Next day, the blots were incubated with second
antibodies and the incubated with supersignal west pico chemi-
luminescent substrate (Thermo Scientific, Rockford, USA). The
membrane was then placed in a Chemidoc XRS unit (BioRad
Laboratories, CA, USA) and the chemiluminescence was detected
by a CCD camera connected to the Chemidoc XRS unit and a
digital output was obtained. The digital image was analysed for
densitometry using Image LabTM Software, Version 3.0 (Bio Rad
Laboratories).
Measurement of Mitochondria Membrane Potential
Mitochondrial membrane potential was determined using
tetramethyl rhodamine methyl ester (TMRM), a lipophilic cation
that selectively accumulates within mitochondria in a membrane
potential depending manner [44]. Briefly, cells were incubated
with 150 nM TMRM after hypoxia for 15 mins at 37uC. Then,
the cells were washed 3 times with PBS gently. After the last wash,
100 ml of PBS was left in plates. Then, TMRM fluorescence was
read immediately on FLUOstar Omega microplate reader with an
excitation wavelength of 544 nm and an emission wavelength of
590 nm. The fluorescence intensity was normalized to cell
number. To visualise TMRM accumulations, cells were incubated
with 150 nM TMRM for 30 mins at 37uC after hypoxia, and then
washed with media. Cells were visualised in Image Xpress
MICRO system (Molecular Devices).
Cytochrome C Translocation
Cytochrome c translocation was determined as previously
described [45]. Briefly, cells were incubated with 200 nM
MitoTracker Orange CMTMRos after inducing hypoxia for
20 mins at 37uC to localize the mitochondria. Then, cells were
fixed in 4% paraformaldehyde for 10 min followed by permea-
bilization in 1% Triton X-100. After washing with PBS, cells were
blocked in 20% goat serum for 30 mins at 37uC and then
incubated with cytochrome c antibody (1:100) for 1 hr at 37uC.
Subsequently, cells were incubated with Alexa Fluor H488
conjugated goat anti-mouse IgG (1:1000) for 1 hr at 37uC. After
the incubation, cells were washed 4 times with PBS and DAPI
(1:2000) was included in the second wash for 10 mins as nuclear
counterstaining. The cell images were obtained using Image
Xpress MICRO system (Molecular Devices) at 20X magnification
with binning of 1 and gain of 2 using laser-based focusing. Images
were captured using a DAPI filter (350/70 nm Ex, 470/50 nm
Em for DAPI), GFP filter (490/40 nm Ex, 510/50 nm Em for
Cytochrome c) and Cy3 filter (550/35 nm Ex, 570/30 nm Em for
MitoTracker Orange CMTMRos).
Statistical Analysis
Results were expressed as means 6 SEM. Statistical differences
among groups were analysed by one-way analysis of variance
(ANOVA), and p value less than 0.05 was considered as
statistically significant.
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